The global Artificial Pancreas Devices Systems market size was valued at US$ 104 million in 2024 and is forecast to a readjusted size of USD 225 million by 2031 with a CAGR of 11.8% during review period.
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report is a detailed and comprehensive analysis for global Artificial Pancreas Devices Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Artificial Pancreas Devices Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2020-2031
Global Artificial Pancreas Devices Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2020-2031
Global Artificial Pancreas Devices Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2020-2031
Global Artificial Pancreas Devices Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Pancreas Devices Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Pancreas Devices Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Artificial Pancreas Devices Systems market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
麻豆原创 segment by Application
Hospitals
Clinics
Major players covered
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Pancreas Devices Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Artificial Pancreas Devices Systems, with price, sales quantity, revenue, and global market share of Artificial Pancreas Devices Systems from 2020 to 2025.
Chapter 3, the Artificial Pancreas Devices Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Pancreas Devices Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Artificial Pancreas Devices Systems market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Artificial Pancreas Devices Systems.
Chapter 14 and 15, to describe Artificial Pancreas Devices Systems sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Artificial Pancreas Devices Systems Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Threshold Suspended Device Systems
1.3.3 Hybrid Closed-loop APDS
1.3.4 Other Systems
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Artificial Pancreas Devices Systems Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Clinics
1.5 Global Artificial Pancreas Devices Systems 麻豆原创 Size & Forecast
1.5.1 Global Artificial Pancreas Devices Systems Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Artificial Pancreas Devices Systems Sales Quantity (2020-2031)
1.5.3 Global Artificial Pancreas Devices Systems Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Artificial Pancreas Devices Systems Product and Services
2.1.4 Medtronic Artificial Pancreas Devices Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Medtronic Recent Developments/Updates
2.2 Bigfoot Biomedical
2.2.1 Bigfoot Biomedical Details
2.2.2 Bigfoot Biomedical Major Business
2.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Product and Services
2.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Bigfoot Biomedical Recent Developments/Updates
2.3 Beta Bionics
2.3.1 Beta Bionics Details
2.3.2 Beta Bionics Major Business
2.3.3 Beta Bionics Artificial Pancreas Devices Systems Product and Services
2.3.4 Beta Bionics Artificial Pancreas Devices Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Beta Bionics Recent Developments/Updates
2.4 Admetsys
2.4.1 Admetsys Details
2.4.2 Admetsys Major Business
2.4.3 Admetsys Artificial Pancreas Devices Systems Product and Services
2.4.4 Admetsys Artificial Pancreas Devices Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Admetsys Recent Developments/Updates
2.5 Insulet
2.5.1 Insulet Details
2.5.2 Insulet Major Business
2.5.3 Insulet Artificial Pancreas Devices Systems Product and Services
2.5.4 Insulet Artificial Pancreas Devices Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Insulet Recent Developments/Updates
2.6 Tandem Diabetes Care
2.6.1 Tandem Diabetes Care Details
2.6.2 Tandem Diabetes Care Major Business
2.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Product and Services
2.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Tandem Diabetes Care Recent Developments/Updates
2.7 Defymed
2.7.1 Defymed Details
2.7.2 Defymed Major Business
2.7.3 Defymed Artificial Pancreas Devices Systems Product and Services
2.7.4 Defymed Artificial Pancreas Devices Systems Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Defymed Recent Developments/Updates
3 Competitive Environment: Artificial Pancreas Devices Systems by Manufacturer
3.1 Global Artificial Pancreas Devices Systems Sales Quantity by Manufacturer (2020-2025)
3.2 Global Artificial Pancreas Devices Systems Revenue by Manufacturer (2020-2025)
3.3 Global Artificial Pancreas Devices Systems Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Artificial Pancreas Devices Systems by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Artificial Pancreas Devices Systems Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Artificial Pancreas Devices Systems Manufacturer 麻豆原创 Share in 2024
3.5 Artificial Pancreas Devices Systems 麻豆原创: Overall Company Footprint Analysis
3.5.1 Artificial Pancreas Devices Systems 麻豆原创: Region Footprint
3.5.2 Artificial Pancreas Devices Systems 麻豆原创: Company Product Type Footprint
3.5.3 Artificial Pancreas Devices Systems 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Artificial Pancreas Devices Systems 麻豆原创 Size by Region
4.1.1 Global Artificial Pancreas Devices Systems Sales Quantity by Region (2020-2031)
4.1.2 Global Artificial Pancreas Devices Systems Consumption Value by Region (2020-2031)
4.1.3 Global Artificial Pancreas Devices Systems Average Price by Region (2020-2031)
4.2 North America Artificial Pancreas Devices Systems Consumption Value (2020-2031)
4.3 Europe Artificial Pancreas Devices Systems Consumption Value (2020-2031)
4.4 Asia-Pacific Artificial Pancreas Devices Systems Consumption Value (2020-2031)
4.5 South America Artificial Pancreas Devices Systems Consumption Value (2020-2031)
4.6 Middle East & Africa Artificial Pancreas Devices Systems Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Artificial Pancreas Devices Systems Sales Quantity by Type (2020-2031)
5.2 Global Artificial Pancreas Devices Systems Consumption Value by Type (2020-2031)
5.3 Global Artificial Pancreas Devices Systems Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Artificial Pancreas Devices Systems Sales Quantity by Application (2020-2031)
6.2 Global Artificial Pancreas Devices Systems Consumption Value by Application (2020-2031)
6.3 Global Artificial Pancreas Devices Systems Average Price by Application (2020-2031)
7 North America
7.1 North America Artificial Pancreas Devices Systems Sales Quantity by Type (2020-2031)
7.2 North America Artificial Pancreas Devices Systems Sales Quantity by Application (2020-2031)
7.3 North America Artificial Pancreas Devices Systems 麻豆原创 Size by Country
7.3.1 North America Artificial Pancreas Devices Systems Sales Quantity by Country (2020-2031)
7.3.2 North America Artificial Pancreas Devices Systems Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Artificial Pancreas Devices Systems Sales Quantity by Type (2020-2031)
8.2 Europe Artificial Pancreas Devices Systems Sales Quantity by Application (2020-2031)
8.3 Europe Artificial Pancreas Devices Systems 麻豆原创 Size by Country
8.3.1 Europe Artificial Pancreas Devices Systems Sales Quantity by Country (2020-2031)
8.3.2 Europe Artificial Pancreas Devices Systems Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Artificial Pancreas Devices Systems Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Artificial Pancreas Devices Systems Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Artificial Pancreas Devices Systems 麻豆原创 Size by Region
9.3.1 Asia-Pacific Artificial Pancreas Devices Systems Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Artificial Pancreas Devices Systems Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Artificial Pancreas Devices Systems Sales Quantity by Type (2020-2031)
10.2 South America Artificial Pancreas Devices Systems Sales Quantity by Application (2020-2031)
10.3 South America Artificial Pancreas Devices Systems 麻豆原创 Size by Country
10.3.1 South America Artificial Pancreas Devices Systems Sales Quantity by Country (2020-2031)
10.3.2 South America Artificial Pancreas Devices Systems Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Artificial Pancreas Devices Systems Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Artificial Pancreas Devices Systems Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Artificial Pancreas Devices Systems 麻豆原创 Size by Country
11.3.1 Middle East & Africa Artificial Pancreas Devices Systems Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Artificial Pancreas Devices Systems Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Artificial Pancreas Devices Systems 麻豆原创 Drivers
12.2 Artificial Pancreas Devices Systems 麻豆原创 Restraints
12.3 Artificial Pancreas Devices Systems Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Artificial Pancreas Devices Systems and Key Manufacturers
13.2 Manufacturing Costs Percentage of Artificial Pancreas Devices Systems
13.3 Artificial Pancreas Devices Systems Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Artificial Pancreas Devices Systems Typical Distributors
14.3 Artificial Pancreas Devices Systems Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
听
听
*If Applicable.
